NLRP3 and autoimmune polyendocrinopathy: A key mechanism underlying the immunomodulatory effects of APS appears to be the direct or indirect modulation of NLR signaling pathways, particularly the NLRP3 inflammasome, providing a molecular basis for its anti-inflammatory properties.